NEW YORK, June 10 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
The Australian asthma/COPD market grew from $278m in 2006 to $333m in 2009. Its growth will slow considerably with the market projected to reach revenues of $354m in 2019. As new drugs launched will be me-too products or combinations of existing classes, Datamonitor assumes that these will be priced similarly to current brands in order to receive reimbursement, leading to a stabilizing market.
Reasons to Purchase
*Identify opportunities and threats that will impact the Australian asthma/COPD market as a whole and key brands and pipeline products in particular.
*Quantify the future size and Scope of the Australian asthma/COPD market and predict the performance of its key compounds.
*Understand critical success factors in growing and defending asthma/COPD brand franchises from new entrants and generics.
To order this report:
Intl: +1 805-652-2626